Inteligencia IAMay 15, 2026Inteligencia IA
Artigo
Citius Oncology reported positive progress in the launch of LYMPHIR®.
First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.
Editorial Data Cube AIFonte: PR Newswire
01
Brief da fonte
Citius Oncology reported positive progress in the launch of LYMPHIR®. First-half fiscal 2026 revenue reached $5.6 million, with broad payer coverage already established.
02